Testing effectiveness (Phase 2)UnknownNCT03229096
What this trial is testing
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Who this might be right for
Chemotherapy EffectChemotherapeutic ToxicityGastric Cancer
Shanghai Zhongshan Hospital 35